NCT04379102 is a clinical trial of with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) ) in IUD, sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

Who is sponsoring NCT04379102?

NCT04379102 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

What drugs are being tested in NCT04379102?

Interventions in NCT04379102: with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) ).

What condition does NCT04379102 study?

NCT04379102 studies IUD, Contraception, Pain.

Is NCT04379102 still recruiting?

NCT04379102 is currently completed. Last updated 8 May 2020.

Last reviewed 2020-05-08 · How we verify

NCT04379102

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application

Completed Last updated 8 May 2020

What this trial tests

trial testing with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) ) in IUD in 80 participants. Completed in 1 July 2019.

Timeline

20 January 2018

Primary endpoint
20 June 2019

1 July 2019

Quick facts

Lead sponsor	Kanuni Sultan Suleyman Training and Research Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	20 January 2018
Primary completion	20 June 2019
Estimated completion	1 July 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )

Conditions studied

IUD — all drugs for IUD →
Contraception — all drugs for Contraception →
Pain — all drugs for Pain →

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 18 to 45, female only, with IUD or Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients who visited our family planning clinic and opted for IUD application for contraception purposes were also offered NT/TLA treatments simultaneously. 40 patients who matched the inclusion criteria and received IUDs and NT/TLA treatments were included in the study group and 41 patients who only received IUDs were included in the control group. All patients received copper IUDs and none of them were on additional hormonal treatment. Before the insertion of IUD, women in the therapy group received NT treatment with 6ml of 1% procaine injected transvaginal into the cervix at 5 and 7 o'clock localizations. Following IUD insertion, another 6ml of 1% procaine was injected into the Frankenhauser ganglia bilaterally. A final dose of 8ml of 1% procaine was injected into the abdominal trigger points and intracutaneously into the L4-S4 dermatomes as quaddles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for IUD

Currently open trials in the same condition.

NCT06240260 — TENS Unit for Analgesia During IUD Insertion · NA · recruiting
NCT05339555 — IUD Self-Removal Study · NA · recruiting

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04379102 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
Last refreshed: 8 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04379102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing